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Introduction
Colorectal cancer (CRC) remains one of the leading causes
of cancer death in the West and in 2002 is estimated to have
affected 148 000 and 22 000 people in the USA and UK,
respectively [1, 2]. CRC develops in 5%–6% of the adult
population, and almost 50% die as a consequence of the dis-
ease [3, 4]. Colonoscopy is now widely accepted as the gold
standard for the early detection of colorectal cancer with
evidence to support a direct mortality reduction in cohorts
undergoing screening sigmoidoscopy [5, 6]. Furthermore,
total colonoscopy has been shown to reduce the incidence of
colorectal cancer in patients with adenomatous polyps [7].
These data support the effectiveness of colonoscopy for the
detection of CRC and polypectomy in the secondary pre-
vention of CRC. Furthermore, the prognosis of patients with
CRC is dependent on the early detection of disease, with
95% and <50% 5-year survivals observed in patients with
stage T1 and T3/4 disease, respectively [8]. Data from Japan
[9] and our group in the UK [10–12] now suggest that stage
Tim/1 disease can be curatively treated using novel endolu-
minal resection techniques such as endoscopic mucosal
resection (EMR) and endoscopic submucosal dissection
(ESD). However, despite these data, evidence to suggest
failure in secondary prevention of CRC by total
colonoscopy and polypectomy is emerging [13–15]. Many
reasons may account for these data [16–19]. Importantly,
new endoscopic techniques such as chromoscopic
colonoscopy and high-magnification chromoscopic
colonoscopy (HMCC) have highlighted the clinical impor-
tance of flat and depressed non-polypoid colorectal lesions
which until recently were believed to be a purely Japanese
phenomena know as ‘phantom carcinoma’or Akita’s disease
[19]. Such lesions are difficult to detect using conventional
white light colonoscopic techniques and barium studies, but
have significant clinicopathological characteristics [20].
Clinically, such lesions have now been shown to have a sig-
nificant prevalence within Western cohorts [21–25]. Data
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Abstract Colorectal cancer remains a leading cause of
cancer death in the UK. With the advent of screening pro-
grammes and developing techniques designed to treat and
stage colorectal neoplasia, there is increasing pressure on
the colonoscopist to keep up to date with the latest prac-
tices in this area. This review looks at the basic principles
behind endoscopic mucosal resection and forward to the
potential endoscopic tools, including high-magnification
chromoscopic colonoscopy, high-frequency miniprobe
ultrasound and confocal laser scanning endomicroscopic
colonoscopy, that may soon become part of routine col-
orectal cancer management.
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scopic resection techniques such as EMR and ESD are
applicable to Western endoscopic practice.
Endoscopic mucosal resection
Following the initial description of EMR or the ‘strip biopsy
technique’by Dehyle et al. [26], EMR has been developed by
Japanese endoscopists for the resection of sessile and flat
lesions of the stomach, oesophagus and colorectum [27]. For
pedunculated lesions this technique is not required, as simple
snare resection is adequate. EMR permits the resection of flat
and sessile lesions by longitudinal section through the sub-
mucosal layer [28]. In the colorectum, EMR may provide
curative resection for flat and sessile adenomas in addition to
early colorectal cancer [28]. For lesions less than 20 mm
diameter, en-bloc EMR facilitates complete histological
analysis of the resected lesion and makes it possible to deter-
mine precisely the completeness of excision in both the hor-
izontal and vertical resection planes [29]. Complete excision
may be possible in the majority of cases, with R0 resection
rates as high as 96% being described [30]. For lesions greater
than 20 mm diameter, historically piecemeal dissection has
been required. The principle limitation to piecemeal dissec-
tion is the inability to assess the vertical and horizontal resec-
tion margins with lesions defaulting at histopathological
analysis to Rx (margins not discernable). However, rates for
en bloc resection and en bloc plus histopathologically con-
firmed R0 status of 88.6% and 62.9%, respectively, by ESD
have now been described in Western practice and are compa-
rable to the preliminary data from Japan [29]. Such endo-
scopic resection techniques are preferable to primary tissue
ablation such as argon plasma coagulation [31] and electro-
coagulation [32] as a definitive histopathological specimen
guides subsequent endoscopic and clinical management in
the majority of cases. Numerous EMR techniques have now
been described which include the lift and cut technique, trac-
tion-assisted resection, and that using a transparent cap fitted
to the proximal aspect of the endoscope [33] in conjunction
with an insulation-tipped cutting knife [34]. While these
techniques are primarily reserved for resection of
oesophageal, gastric and submucosal posterior rectal tumours
[27, 34], ESD has now been shown to be both safe and feasi-
ble for the resection of tumours up to and beyond the splenic
flexure [35] although this remains a developmental technique
not in routine practice at many centres in Europe.
Basic EMR technique
The technique of EMR (Fig. 1) comprises 4 stages:
1. Diagnosis and localisation of the lesion.
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2. Evaluation of invasive depth to exclude lesions invad-
ing the deep submucosal layer 3 or beyond (i.e. T2 dis-
ease) using HMCC or ultrasonography (US).
3. Excision procedure.
4. Post-resection evaluation.
Initial diagnosis and location of flat and sessile lesions
of the colorectum are facilitated by the use of indigo
carmine (IC) chromoscopy, which allows observation of
detailed morphology [9]. Lesions should then be described
according to Paris Workshop guidelines (Table 1). Narrow
band imaging (NBI) is an alternative technique in which
modified optical filters are used in the light source of the
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Fig. 1a-f Endoscopic mucosal resection (EMR). a A G-type lateral
spreading tumour of the ascending caecal junction viewed in full
retroflexion. b Indigo carmine (0.5%) chromoscopy clearly delin-
eates the tumour margins and nodularity. c Submucosal cannula-
tion provides a symmetrical and sustained ‘lift’prior to submucos-
al dissection. d The exposed post-dissection ‘stranding’of the mus-
cularis can be clearly identified following assessment of the post-
resection margins using indigo carmine chromoscopy. e Argon
plasma ablation is applied to the circumferential margins of the
resection. f Endoscopic appearances of the lesion 12 weeks after
resection. There is complete epithelial restoration with a mucosal
type I crypt pattern. Curative resection has been achieved
ab
cd
efvideo-endoscope system to provide ‘virtual chromoscopy’.
Provisional data suggest comparable rates of diagnostic
accuracy of NBI [36, 37] to IC chromoscopy. Further ran-
domised controlled trials are now required to clarify this
issue prior to implementation of NBI into routine clinical
practice.
In vivo staging of lesions can be achieved using HMCC
(Table 2) [38], the Olympus Lucera differential of haema-
globin indices function (Hib) (Olympus Lucera, Tokyo,
Japan) for vascular ectasia mapping and through-the-scope
miniprobe US (12.5–20 MHz), either alone or as a multi-
modality technique (Table 3) [39]. Flat and sessile lesions
up to 20 mm in diameter can be resected by en bloc or ‘sin-
gle pass’ resection, but larger lesions usually require a
piecemeal approach [29]. A needle catheter is then insert-
ed through the side port of the colonoscope with sterile
saline or an alternative submucosal solute (e.g. sodium
hyaluronic acid, glycerol, 50% dextrose solution) injected
peripherally and centrally into the lesion and surrounding
mucosa. Acleavage of the submucosa (having the effect of
raising the lesion) then permits simple snare resection. A
single cannulation can be used for small lesions (<10 mm
diameter) with multiple cannulations usually required for
lesions of 20 mm or more [29]. Some authors advocated
the use of adrenaline (1:100 000) mixed with saline or
twice-normal saline at submucosal injection to maintain a
‘dry’ dissection field [40]. 50% dextrose solution was
shown to provide a longer duration of lift, with smaller
injection volumes and higher rates of en-bloc resection,
although there were no differences in completeness of
resection or complications in the total cohort in
Varadarajulu et al.’s study [41]. Other studies have utilised
a number of solutes including hyaluronic acid, hydrox-
ypropyl methylcellulose and glycerol, with demonstrably
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Table 1 Paris Workshop guidelines [56] for the gross morphological classification of colorectal lesions
Endoscopic appearance Paris class Form Description
Protruded lesions Ip Pedunculated polyps
Ips Subpedunculated polyps
Is Sessile polyps
Flat elevated lesions 0-IIa Flat elevation of mucosa
0-IIa /c Flat elevation with central depression
Flat lesions 0-IIb Flat mucosal change
0-IIc Mucosal depression
0-IIc / IIa Mucosal depression with raised edge
Table 2 The modified Kudo criteria for the classification of colorectal crypt architecture in vivo using high-magnification chromoscopic
colonoscopy (HMCC)
Pit type Characteristics Appearance at HMCC Pit size, mm
I Normal round pits 0.07±0.02
II Stella or papillary 0.09±0.02
IIIs Tubular, round pits, smaller than pit type I 0.03±0.01
IIIL Tubular, large 0.22±0.09
IV Sulcus, gyrus 0.93±0.32
V(a) Irregular arrangement and sizes of IIIL, IIIs, IV type pits NA
NA, not applicablebetter and longer lasting mucosal lift [42–44]. However,
no randomised controlled trial has proved superiority with
regard to resection clearance (with specific reference to R0
resection rates), post-EMR haemorrhage or perforation.
Whatever injection medium used, it is essential to main-
tain a sufficient mucosal lift or detachment throughout the
dissection, which minimises the risk of the muscularis pro-
pria being trapped within the vertical resection plane of the
snare and subsequent perforation [27].
After resection, evaluation of the mucosal defect is
mandatory, as remnant neoplastic tissue continues to
assume an overall risk of progression to invasive neopla-
sia. Complete resection in the horizontal axis can be
determined using IC chromoscopy by the identification of
a normal type I pit pattern (as defined by the modified
Kudo criteria [38]). Remnant neoplastic tissue (as identi-
fied by Kudo crypt types IIIL, IV or V) suggests R1
resection status and should prompt the endoscopist to
extend the initial resection or employ an adjunctive abla-
tive technique such as APC to the positive resection mar-
gins [45]. The Sheffield group advocate peripheral mar-
gin tattoos prior to submucosal injection that delineates
the normal mucosal boundaries around the lesion prior to
resection [46]. This technique may facilitate R0 resection,
as at submucosal lift, the lesion can become distorted and
indistinct from the surrounding normal mucosa [46]. If
the lesion fails to lift (the non-lifting sign of Uno) or has
an asymmetrical appearance, then the resection should be
abandoned as this indicates tethering to the underlying
muscularis mucosa [47]. Perforation and risk of non-cura-
tive resection can occur in this scenario [47, 48]. All
lesions should have an adjacent submucosal tattoo
applied using India ink or ‘Endo Spot’ endoscopic mark-
er [Ref: GIS-44, Camp Hill, PA 17011] to facilitate local-
isation at follow-up colonoscopy or subsequent surgical
resection [49].
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Following successful submucosal lift, a spiked or
‘barbed’snare is applied over the lesion and slowly closed
under gentle suction [27]. This permits the lesion to be
retained within the snare boundaries before final resection
[27]. Prior to final cutting (usually using a 25 W or 10 W
coagulation current for lesions distal or proximal to the
splenic flexure, respectively), the snare should be relaxed
slightly to allow any entrapped muscularis mucosa to
retract [27]. Following resection, the lesion should be
retrieved using pronged grasping forceps or preferably a
Roth net which limits tissue trauma to the specimen, prior
to ‘pinning out’ and immediate fixation in 10% formalin
solution. Japanese endoscopists ‘pin out’ the lesion onto a
solid cork or polystyrene plate prior to fixation, which lim-
its shrinkage of the resection specimen and permits easier
and more accurate histopathological sectioning [34].
Complications of EMR
The main complications of EMR are haemorrhage, perfo-
ration and stenosis [49, 50]. The immediate and early com-
plications (10% of cases) described in the first 12 hours
after resection are principally haemorrhage and rarely per-
foration [50]. The Sheffield group reported bleeding com-
plications in only 2% of patients undergoing EMR in their
cohort of 599 lesions [10], which was significantly lower
than that reported in Ahmed et al.’s retrospective analysis
(22%) [51]. However, other Japanese authors have report-
ed haemorrhage rates after colonic EMR of 1.16% (10 of
863) [52], comparable to those observed in the Sheffield
series [10]. Okamoto et al.’s review of interventional
colonoscopic resections also reported a perforation rate
secondary to EMR of only 0.35% [50], and Kaneko et al.’s
multicentre analysis of endoscopic mortality showed rates
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Table 3 Clinical criteria for submucosal invasive depth estimation using four different diagnostic imaging techniques 
Histopathology HMCC Hib vascular ectasia mapping Combined HMCC and  High-frequency miniprobe 
vascular ectasia mapping endoscopic US
Tis/sm1 Crypt A:
crypt fully defined Normal vascular pattern Crypt A + normal  Hypoechoic mass within 
vascular pattern first hypoechoic layer
sm2 Crypt B:
crypt partially defined Vessel tortuosity  Crypt B + vessel  Hypoechoic mass 
with dilatation tortuosity with dilatation infiltrating second
hypoechoic layer
sm3 Crypt C:
crypt not defined  Complete disruption of  Crypt C + complete  Hypoechoic mass 
or absent vascular architecture disruption of vascular infiltrating third layer 
architecture +/- extension to hyperechoic
muscularis
US, ultrasonographyof less than 0.0001% for this procedure [53]. In Hurlstone
et al.’s evaluation of 599 EMR procedures, no patient
required emergency laparotomy for bleeding or perfora-
tion, whilst 15 (2.5%) had incomplete vertical excision
margins with 9 requiring surgical excision (<1%) at a
median of 3.5 years follow-up [10]. EMR may therefore be
a safe and effective endoscopic therapy that may enhance
our current strategies aimed at the secondary prevention of
colorectal cancer.
Endoscopic submucosal dissection
ESD allows en bloc knife dissection of lesions usually in
excess of 20 mm diameter to the vertical depth of the mus-
cularis mucosa [54, 55]. Determination of the morpholog-
ical class by chromoscopic colonoscopy as per the Paris
consensus criteria [56] and on-table staging of the lesion
by high-frequency ultrasound (HFUS) with differentiation
of tumour stage and nodal disease status as per the Cho cri-
teria [57] enables accurate assessment as to the feasibility
of ESD. Lesions with a fixed Paris type IIc component
(defined as a fixed depression whether air is insufflated or
deflated) or Cho criteria for T2/N1 disease are not
amenable to ESD (Fig. 2). Following submucosal catheter-
isation and lifting with either sodium hyaluronic acid or
glycerol submucosal infiltration, circumferential mucosal
incisions are made at 5- to 6-mm intervals around the pan-
circumference of the lesion. Submucosal dissection can
then be initiated from the most proximal aspect of the
lesion using the insulation-tipped knife. Maintenance of
the dissection plane, by patient manoeuvring, in addition
to direct tissue traction from the distally attached endo-
scopic dissection assistance cap, enables visualisation of
the exposed muscularis layer and reduces the risk of per-
foration. The resected specimen can be retrieved by Roth
net and then pinned out (to reduce shrinkage) before
undergoing histological assessment for resection com-
pleteness (i.e. R stage). 
Complications of ESD
As with EMR, the main complications include haemor-
rhage and perforation [54, 55, 58, 59] with Fujishiro et al.
[59] reporting a bleeding rate of 12% and an overall per-
foration rate of 5.7% (2 of 35). However, in this series,
both perforations were treated conservatively without need
for surgical intervention [59]. The learning curve and opti-
mal teaching modality for ESD have not yet been
described in the literature, but this is now required should
this novel yet technically demanding endoscopic technique
become adopted outside of tertiary referral practice.
Evolving technology for the future
Magnification chromoscopy
Accurate in vivo staging is essential at colonoscopy prior
to consideration of local endoluminal resection. Flat focal
submucosal invasive CRCs which are limited to the sub-
mucosal layer 1 can be managed by EMR as the risk of
lymphovenous invasion and nodal metastasis is low (<5%)
[60–62]. For lesions with deeper vertical invasion into the
submucosal layer 3 or beyond (stage T2), the risk of nodal
disease increases to 10%–15% [63]. EMR in this group is
therefore undesirable due to a higher risk of perforation,
non-curative excision and untreated nodal disease [28].
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Fig. 2a-c Lesion with a fixed Paris type IIC component not amenable to endoscopic submucosal dissection (ESD). a Nodularity of fold
noted using conventional colonoscopy in the mid-ascending colon. b Indigo carmine (0.5%) chromoscopy shows a diminutive Paris type
0-II lesion. c Zoom view at 30x magnification shows a clear type 0-IIc depressed component to the lesion. An invasive adenocarcinoma
(stage T2/N0) was evident at post-surgical resection histopathology
a b cSurgical excision is recommended in this group [28, 34].
Chromoscopic colonoscopy used as an in vivo staging
tool has been reported by Saitoh et al. [64]. In this retro-
spective analysis of depressed type early CRCs, combined
video-endoscopy and chromoscopy was used to charac-
terise the essential endoscopic features favoured by lesions
with submucosal layer 1 and 2 invasion, which at the time
of endoscopy may be used as a tool to guide the colono-
scopic management (i.e. attempted EMR or biopsy alone
with surgical referral) [64]. Using Saitoh et al.’s criteria
(expansion appearance, present; surface depression, deep;
irregularity of depressed surface, uneven; and converging
folds toward the tumour), the sensitivity and specificity for
determining submucosal layer 2 disease were both 90%
[64]. However, when 21 lesions showing intramucosal car-
cinoma were excluded from the analysis, specificity fell to
70% [64]. In Hurlstone et al.’s prospective analysis of
endoscopic morphological anticipation of submucosal
invasion in flat and depressed lesions [65] using the
Nagata subtype analysis [66] of the Kudo type V pit pat-
tern [38], the K coefficient of agreement between pit type
V and histologically confirmed sm2 invasion was 0.51.
Using pit types Vn(B) and Vn(C) as clinical indicators of
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invasive disease, 97% of lesions was correctly anticipated
to have sm2+ invasion; however, specificity was low at
50% (overall accuracy, 78%) [65]. Similar problems have
been encountered using the 7.5 MHz ultrasound probe in
the staging of rectal carcinoma, with variable accuracy
rates reported (from 60% to 79%) according to the T stage
system [67, 68]. High-frequency 20 MHz ‘miniprobe’
ultrasound has now been reported to have a high overall
accuracy when used to determine submucosal invasion for
flat and depressed lesions (Fig. 3) [69] with 93% accuracy
in determining invasive depth staging and 80% sensitivity
for predicting lymph node metastasis [70]. However, ultra-
sound imaging requires further training, has significant
expense and may prolong the procedure [70]. 
In summary, the limitations of HMCC technology are:
- High sensitivity and specificity for the differentiation
of non-neoplastic from neoplastic disease, but low
overall sensitivity for the anticipation of high-grade
dysplasia.
- Effective over-staging of submucosal layer 3 / T1 neo-
plasia.
- Significant operator-dependent error.
Autofluorescence colonoscopy
Chromoscopic and high-magnification techniques have been
introduced in an attempt to improve the sensitivity and speci-
ficity of ‘white-light’ colonoscopy. However, a new endo-
scopic technology that is fluorescence-based is under evalu-
ation by many groups [71, 72]. This technology exploits
either the autofluorescence of naturally occurring molecules,
such as collagen, NAD-H, flavins and porphyrins, or the flu-
orescence of exogenously administered fluorescent drugs.
The detection of neoplastic lesions using autofluores-
cence depends on subtle changes in the concentration or dis-
tribution in depth of endogenous fluorophores, changes in
tissue micro-architecture and altered mucosal thickness or
blood concentrations [73]. All these factors affect the fluo-
rescence intensity or spectrum due to wavelength-specific
light absorption [73]. Using exogenous fluorophores, the
detection of lesions is based on selective drug uptake or tar-
get tissue retention relative to uptake by normal tissue [73].
Kapadia et al. used ultraviolet (UV) light in the colon
to discriminate normal mucosa, adenomas and hyperplas-
tic lesions with accuracies of 100%, 100% and 94%,
respectively [72]. In the first in vivo human colonic spec-
troscopic study by Cothren et al., differentiation between
adenoma and non-adenomatous lesions was achieved in
97% of cases [74]. Cothren et al. in the first blinded study
also identified colonic dysplasia with 90% sensitivity and
95% specificity [75].
However, the clinical potential of spectroscopy in rou-
tine endoscopic practice has not yet been clarified.
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Fig. 3a-d High-frequency miniprobe ultrasonography. a Focal ery-
thema and nodularity present in the distal sigmoid colon at con-
ventional endoscopy. b Indigo carmine (0.5%) chromoscopy delin-
eates a flat Paris type 0-IIa lateral spreading tumour. c High-fre-
quency ‘through the scope’miniprobe 12.5 MHz endoscopic ultra-
sound shows bluring of the submucosal layer 1/2 but a preserved
muscularis (thick adjacent hyperechoic band). There is no associat-
ed per-colic lymphadenopathy. Endoscopic submucosal dissection
is indicated given the ‘on-table stage’ of Tim/N0. d Endoscopic
view of the lesion 1 month after resection. Note the granulation tis-
sue present at the resection base with a surrounding normal type I
crypt architecture. Curative resection was achieved
ab
cdChwirot et al. performed multi-spectral autofluorescence
imaging in the colon of polyps ex vivo [76], and Wang et
al. recently described a prototype fluorescence imaging
system applied ex vivo to detect and localise adenomas in
colectomy specimens from patients with familial adeno-
matous polyposis [77]. A second-generation fluorescence
imaging system was described by Wang et al. in 1999 for
the in vivo detection of colorectal adenomas in which UV
light was transmitted through a fibre-optic bundle inserted
through the side port of the endoscope [78]. A video-
colonoscope was then used to capture the fluorescence
light within the wavelength band 400–700 nm [78]. False-
colour images were then overlaid onto the conventional
white-light images, displaying regions where the fluores-
cence intensity exceeded threshold values relative to a
moving image [78]. In this study of 30 patients, 18 lesions
visible with white-light imaging were examined, all 6
hyperplastic lesions were correctly identified, and the sen-
sitivity for dysplasia was 83% [78]. However, despite
these encouraging initial data, further studies are required
before such technology can be implemented in routine
endoscopic clinical practice.
Confocal laser endomicroscopic colonoscopy
Given the limitations of HMCC and autofluorescence,
laser scanning confocal microscopy (LCM) has recently
been developed as an alternative means of in vivo
histopathological diagnosis. LCM is an adaptation of light
microscopy whereby focal laser illumination is combined
with ‘pinhole limited detection’to geometrically reject out
of focus light. In single-point scanning confocal micro-
scopes, the point is typically scanned in a raster pattern
and measurements of light returning to the detector from
successive points are digitized so an image of the scanned
region can be constructed. Each resultant image is an
‘optical section’ representing approximately one focal
plane within the specimen (Fig. 4).
The components of the laser confocal colonoscope are
based on the integration of a confocal laser microscope
mounted in the tip of a conventional colonoscope
(EC3870K; Pentax, Tokyo, Japan), which enables confocal
microscopy in addition to standard videoendoscopy.
During LCM, an argon ion laser delivers light at an exci-
tation wavelength of 488 nm with a maximum laser output
of <1 mW at the surface mucosa. Confocal images can
then be collected at a scan rate of 0.8 frames per second
(1024x1024 pixels) or 1.6 frames per second (1024x512
pixels). The optical slice thickness is 7 µm with a lateral
resolution of 0.7 µm and a z-axis range of 0–250 µm below
the surface layer.
Conclusions
There is much further potential for evolving practice and
research at the present time. The key areas at present we
perceive are:
- Early cancer detection and intraepithelial neoplasia
detection in sporadic colorectal cancer and chronic
ulcerative colitis.
- Targeted “smart” biopsies using confocal laser scanning
endomicroscopy. This technique would optimise the yield
of high quality biopsies being interpreted by histopathol-
ogists and confer significant economic benefits.
- Advanced endoscopic resection practice.
This review shows that emerging concepts in endo-
scopic detection and therapeutic techniques, initially pio-
neered by the Japanese, are applicable to Western practice.
We hope that chromoscopic colonoscopy and magnifica-
tion imaging in addition to EMR will now be more widely
practiced by both surgical and medical gastroenterologists.
However, while differences remain between Japanese and
Western classification systems it is difficult to extrapolate
endoscopic and pathological data reported in Japanese
studies to our practice. Furthermore, additional studies are
required to clarify the role of chromoscopic colonoscopy
and magnification imaging in routine clinical practice.
Confocal endomicroscopy may change the in vivo diag-
nostic paradigm once again. Finally, all practitioners
require further education and training, if new diagnostic
techniques and therapeutic procedures are to be adopted.
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